BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28364231)

  • 1. Aggregation and Disaggregation of Morpholino Oligomers in Solution.
    Chow G; Morcos PA; Moulton HM
    Methods Mol Biol; 2017; 1565():31-38. PubMed ID: 28364231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Bacterial Growth by Peptide-Conjugated Morpholino Oligomers.
    Daly SM; Sturge CR; Greenberg DE
    Methods Mol Biol; 2017; 1565():115-122. PubMed ID: 28364238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invention and Early History of Morpholinos: From Pipe Dream to Practical Products.
    Summerton JE
    Methods Mol Biol; 2017; 1565():1-15. PubMed ID: 28364229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making a Morpholino Experiment Work: Controls, Favoring Specificity, Improving Efficacy, Storage, and Dose.
    Moulton JD
    Methods Mol Biol; 2017; 1565():17-29. PubMed ID: 28364230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Delivery of Morpholinos to Skip Multiple Exons in a Dog Model of Duchenne Muscular Dystrophy.
    Maruyama R; Echigoya Y; Caluseriu O; Aoki Y; Takeda S; Yokota T
    Methods Mol Biol; 2017; 1565():201-213. PubMed ID: 28364245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of Morpholino Monomers, Chlorophosphoramidate Monomers, and Solid-Phase Synthesis of Short Morpholino Oligomers.
    Bhadra J; Pattanayak S; Sinha S
    Curr Protoc Nucleic Acid Chem; 2015 Sep; 62():4.65.1-4.65.26. PubMed ID: 26380905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible Inhibition of Gene Function with Photomorpholinos.
    Sumanas S
    Methods Mol Biol; 2017; 1565():51-57. PubMed ID: 28364233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial control of gene function with wavelength-selective caged morpholinos.
    Pattanayak S; Vázquez-Maldonado LA; Deiters A; Chen JK
    Methods Enzymol; 2019; 624():69-88. PubMed ID: 31370936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing antisense oligonucleotides using phosphorodiamidate morpholino oligomers.
    Popplewell LJ; Malerba A; Dickson G
    Methods Mol Biol; 2012; 867():143-67. PubMed ID: 22454060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Validation of Phosphorodiamidate Morpholino Oligomers.
    Aung-Htut MT; McIntosh CS; West KA; Fletcher S; Wilton SD
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31408997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Functional Noncoding RNAs.
    Crossley MP; Krude T
    Methods Mol Biol; 2017; 1565():151-160. PubMed ID: 28364241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing Breast Cancer Genes Using Morpholino Embedded DNA-Tile-AuNPs Nanostructures.
    Tunç CU; Öztaş DY; Uzunoğlu D; Bayrak ÖF; Çulha M
    Hum Gene Ther; 2019 Dec; 30(12):1547-1558. PubMed ID: 31608694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivering Antisense Morpholino Oligonucleotides to Target Telomerase Splice Variants in Human Embryonic Stem Cells.
    Radan L; Hughes CS; Teichroeb JH; Postovit LM; Betts DH
    Methods Mol Biol; 2016; 1341():133-42. PubMed ID: 25822725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface Plasmon Resonance-Based Concentration Determination Assay: Label-Free and Antibody-Free Quantification of Morpholinos.
    Boutilier J; Moulton HM
    Methods Mol Biol; 2017; 1565():251-263. PubMed ID: 28364249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative analysis of peptide-delivered antisense antibiotics using diverse nucleotide mimics.
    Ghosh C; Popella L; Dhamodharan V; Jung J; Dietzsch J; Barquist L; Höbartner C; Vogel J
    RNA; 2024 May; 30(6):624-643. PubMed ID: 38413166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan-Shelled Nanobubbles Irreversibly Encapsulate Morpholino Conjugate Antisense Oligonucleotides and Are Ineffective for Phosphorodiamidate Morpholino-Mediated Gene Silencing of
    Falzarano MS; Argenziano M; Marsollier AC; Mariot V; Rossi D; Selvatici R; Dumonceaux J; Cavalli R; Ferlini A
    Nucleic Acid Ther; 2021 Jun; 31(3):201-207. PubMed ID: 32679000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico screening based on predictive algorithms as a design tool for exon skipping oligonucleotides in Duchenne muscular dystrophy.
    Echigoya Y; Mouly V; Garcia L; Yokota T; Duddy W
    PLoS One; 2015; 10(3):e0120058. PubMed ID: 25816009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-penetrating peptides enhance systemic delivery of antisense morpholino oligomers.
    Moulton HM
    Methods Mol Biol; 2012; 867():407-14. PubMed ID: 22454076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-Mediated In Vitro Transfection Technique of Oligonucleotides with Broad Chemical Modification Compatibility.
    Wada F; Hori SI; Obika S; Yamamoto T
    Methods Mol Biol; 2020; 2176():141-154. PubMed ID: 32865788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense oligonucleotide drugs for Duchenne muscular dystrophy: how far have we come and what does the future hold?
    Guncay A; Yokota T
    Future Med Chem; 2015; 7(13):1631-5. PubMed ID: 26423833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.